This document discusses the challenges of reconciling data sharing and privacy protections in value-based health care. It notes that while electronic health records and other technologies are critical for value-based health care, interoperability and data quality issues remain. Ensuring effective data use while respecting individual privacy rights is difficult given the current legal and operational frameworks. The document explores some approaches like trusted exchange frameworks and care integration networks, but concludes these still require balancing the data needs of value-based care with patients' privacy interests.
The document summarizes a study that evaluated the acceptability of a personally controlled health record (PCHR) system called Indivo in a community-based setting. Over 300 participants were involved in formative research activities to understand awareness, beliefs and reactions. The study found moderate awareness of privacy issues and high support for patient autonomy. Results informed guidelines on design improvements, literacy tools, and safety protocols for PCHR systems. Limitations included a lack of detail on methodology and sample selection.
Edifecs: Demonstrating who you are in CJREdifecs Inc
A hands-on approaches for hospitals to strategically align orthopedic surgeons and post-acute providers under CJR. This Presentation focuses on tools that providers can use to help manage their performance to be successful under the new value-based environment.
The document discusses patient support programs for rare and orphan drugs. It notes that orphan drugs have unique challenges including small patient populations, difficulty in diagnosis, and reimbursement challenges. Patient support programs aim to help patients access therapy and navigate reimbursement and clinical support. They provide services like financial assistance, nursing care, pharmacy services, and adherence programs. The goal of these programs is to allow patients access to treatment, assist them in coordinating care, and generate real-world data on drug effectiveness outside of clinical trials to help demonstrate value to payers and accelerate patient access.
This document discusses the Independent Hospital Pricing Authority's (IHPA) work on pricing reforms beyond 2020. Key points include:
1) IHPA sets national efficient prices, develops classification systems, and handles cross-border disputes to promote transparency, value, and efficiency in the public hospital system.
2) IHPA is moving public hospital funding toward an activity-based funding model, with blocks of funding still used in some areas. This has led to a significant slowdown in cost growth.
3) IHPA is developing pricing approaches to incentivize safety, quality and efficiency. This includes not funding episodes involving sentinel events, paying less for episodes complicated by hospital-acquired conditions,
Using real-world evidence to investigate clinical research questionsKarin Verspoor
Adoption of electronic health records to document extensive clinical information brings with it the opportunity to utilise that information to support clinical research, and ultimately to support clinical decision making. In this talk, I discuss both these opportunities and the challenges that we face when working with real-world clinical data, and introduce some of the strategies that we are adopting to make this data more usable, and to extract more value from it. I specifically discuss the use of natural language processing to transform clinical documentation into structured data for this purpose.
The document describes a case study of Massachusetts' Children's High-Risk Asthma Bundled Payment pilot program. The program aims to evaluate if bundled payments to providers can improve health outcomes for high-risk pediatric asthma patients while lowering costs by reducing hospital and emergency department visits. Providers receive $50 per member per month and can use the funds flexibly to provide services like home visits, education, and supplies to better manage patients' asthma. The goal is for the program to generate savings within 3 years by preventing expensive hospital admissions and emergency visits.
Opioid Epidemic - Causes, Impact and FutureCitiusTech
In 2017, everyday, more than 130 people died in the US after overdosing on opioids. This document talks about America's worst drug crisis ever and shares how technology can play a role to cope up with this epidemic.
Real world evidence pharmaceutical industry-plPeter Le
This document discusses the challenges and opportunities of real-world evidence (RWE) in the pharmaceutical industry. It notes that while RWE from real-world data can help improve drug development, operations, and decision-making, there are also challenges to overcome. These include issues with data accessibility, analysis capacity, and balancing limited resources. However, RWE also presents opportunities to increase value, understand effectiveness beyond clinical trials, and gain business insights. Overall, RWE brings significant opportunities if pharmaceutical companies can address solvable challenges through leadership, governance, and transformation.
This document summarizes a study on bibliometric trends in health economic evaluations in sub-Saharan Africa. The study analyzed 345 articles from the NHS EED database to characterize economic evaluations and examine collaboration patterns. It found that evaluations mostly addressed HIV, malaria, and tuberculosis, and focused on treatment interventions. While sub-Saharan authors frequently collaborated with other African researchers from their own country, collaboration between African countries was weaker than with the US and Europe. The study concludes collaboration across African countries should be promoted to support evidence-based decision making.
This document discusses building support networks for patients with rare diseases. It notes that support groups are important for patients to connect with others facing similar challenges, learn about their conditions, and receive emotional support. Support groups help address common issues for rare disease patients like isolation, managing symptoms, and uncertainty. The document advocates training facilitators to support existing groups and creating online toolkits and networks like SPIN to help rare disease patients cope.
The Canadian Hemophilia Society advocated for access to the innovative drug emicizumab (Hemlibra) for Canadians with hemophilia A between 2018-2021. After initial delays, the drug was approved for patients with inhibitors in May 2019 but advocacy continued for broader access. Health technology assessments recommended against funding due to perceived lack of evidence, though patients reported a high disease burden. Advocacy efforts included surveys, letters, media stories, and behind-the-scenes discussions. In August 2021, Quebec partially approved funding while the rest of Canada approved broader public funding in September 2021.
Please share this slideshow with anyone who may be interested!
Watch all our webinars: https://www.youtube.com/playlist?list=PL4dDQscmFYu_ezxuxnAE61hx4JlqAKXpR
In this webinar:
● Discussion of the CADTH Symposium
● Recommendations for HTA improvements in Canada
● Audience Q&A
View the video: https://youtu.be/AJCOemf2r6Y
Follow our social media accounts:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Pinterest - https://www.pinterest.com/survivornetwork
YouTube - https://www.youtube.com/user/Survivornetca
Data Governance for Real-World Evidence: Cross-country differences and recommendations for a governance framework
Cole, A., Garrison, L., Mestre-Ferrandiz, J. & Towse A.
Leveraging Analytics to Identify High Risk PatientsCitiusTech
A predictive analytics platform can help healthcare providers identify which patients and team members could be at the highest risk for severe illness / hospitalization.
Data Governance for Real-World Evidence: Cross-country differences and recomm...Office of Health Economics
This document analyzes data governance frameworks for using real-world data (RWD) to generate real-world evidence (RWE) in eight countries. It identifies 29 elements of an ideal governance framework and assesses each country's framework against these criteria. Recommendations include having clear data protection laws that allow secondary uses of health data to benefit patients, using opt-out consent for large cohort data collection, and transparent data linkage mechanisms with national interoperability standards. Current country frameworks show varying adherence to these recommendations.
The document discusses the complex history and regulations around drug approval and patient access in Europe, highlighting issues like the need for harmonization across countries and rising drug costs putting pressure on health budgets. It also provides an example of how patient advocacy groups like Myeloma Patients Europe work to monitor access barriers in different countries and support national organizations in addressing issues around timely access to new treatments.
1. The document discusses cyber security issues facing health information exchanges (HIEs), including concerns over increasing cyber attacks, mobile devices, medical devices, and lack of funding.
2. Guidelines from the Office of the National Coordinator for Health IT (ONC) require HIEs to develop privacy and security policies to protect patient information according to fair information practice principles.
3. Recommendations to improve HIE cyber security include restricting access, updating antivirus software and firewalls, monitoring networks, and maintaining critical functionality during security incidents. Addressing these issues is key to enabling secure health information exchange.
Three Analytics Strategies to Drive Patient-Centered CareHealth Catalyst
Three analytics strategies enable health systems to focus on patients while also meeting the financial standards for VBC delivery:
1. Prioritize patient outreach by risk level.
2. Deploy data tools to combat COVID-19.
3. Promote data literacy.
Part of the "2016 Annual Conference: Big Data, Health Law, and Bioethics" held at Harvard Law School on May 6, 2016.
This conference aimed to: (1) identify the various ways in which law and ethics intersect with the use of big data in health care and health research, particularly in the United States; (2) understand the way U.S. law (and potentially other legal systems) currently promotes or stands as an obstacle to these potential uses; (3) determine what might be learned from the legal and ethical treatment of uses of big data in other sectors and countries; and (4) examine potential solutions (industry best practices, common law, legislative, executive, domestic and international) for better use of big data in health care and health research in the U.S.
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School 2016 annual conference was organized in collaboration with the Berkman Center for Internet & Society at Harvard University and the Health Ethics and Policy Lab, University of Zurich.
Learn more at http://petrieflom.law.harvard.edu/events/details/2016-annual-conference.
System Request FormDateProject Name Centralizing Medic.docxmattinsonjanel
System Request Form
Date:
Project Name: Centralizing Medical Information To Improve patient Care
Project Sponsor:
Name: Team
Department:Healthcare
Organization:Hospitals
Contact Information: Phone:
Business Problem Statement: Christine Newton
The American Recovery and Reinvestment Act of 2009 were established to interoperable health information technology and qualified electronic health records. Doctors and patients need accurate information to improve the outcome of medical care for proper diagnosis and patients need access to their information regardless of the doctor they choose to visit. The solution to this is a centralized national database system which makes diagnosis and treatment easier for doctors and patients. The centralized database system would allow the focus on patient care instead of the monetization of the care by providing vital medical information necessary to expedite diagnosis.Accurate medical history and quick access to this information is a vital part of patient care for emergency which could save lives, provide medical advances with data analysis and increased diagnosis efficiency.An infrastructure to allow health information exchange between non-affiliated hospitals that participate in Medicaid/Medicare which would allow privacy, provide critical information and improve efficiency would provide this solution.
High-Level Functional Requirements:
Automation of process for maintaining medical records:
1. Access medical information through Pin Number.
1. Provide access of medical information within health care facilities.
1. Access medical information from scanning health card via magnetic strip, or barcode
1. Information that can be accessed could include known allergies, current and past medical conditions.
1. Provide secure way of accessing information, i.e. encryption.
1. Provide for the ability to update and add information in real time.
1. Granting appropriate permissions to Doctors, Paramedics, Patients, etc.
1. Patient authorizes medical personnel access to medical records per HIPAA regulations.
1. Track prescription via medications paid for by Medicaid insurance
High-Level Proposed
Solution
and Business Benefits:
The solution for this type of system is barcode or magnetic strip on insurance cards which would retrieve patient medical. When scanned, important medical information will be readily available to doctors or emergency personnel. This information can then be linked to a centralized database for all hospitals which would be housed by government entity. Currently Medicare/Medicaid hospitals that are nonaffiliated do not have access to customer’s information even though they accept Medicaid; by incorporating a centralized database that each hospital can retrieve information via customer consent with pin number or insurance magnetic strip would resolve this issue.
The main benefits of this system to the government areincrease efficiency, increase productivity, improved diagnosis, decrea ...
Big data in healthcare refers to large, diverse, and complex datasets that are difficult to analyze using traditional methods. The healthcare industry generates huge amounts of data from sources like electronic health records, medical imaging, and fitness trackers. Analyzing this big data can help improve patient outcomes, reduce costs, and advance personalized medicine. However, healthcare also faces challenges like data silos, privacy concerns, and resistance to change. Opportunities include disease prediction and prevention, reducing readmissions and fraud, and optimizing care through remote monitoring. Some organizations are starting to see benefits from big data initiatives focused on areas like evidence-based treatment and integrated health records.
Big data is more than just a buzzword in healthcare. It's the promise of being able to extract, cull, and interpret medical data to directly benefit population and individual health. learn more about the benefits of big data, roadblocks to leveraging it's potential, how Meaningful Use enablesbig data, what types of cross-country collaboration projects are advancing the use of big data on an international scale, big data's impact on patient privacy and much more! Special thanks to Mandi Bishop for her time on the podcast.
Three Analytics Strategies to Drive Patient-Centered CareHealth Catalyst
The cost of uncoordinated care that fails to prioritize patient needs is estimated to be over $27.2 billion. One of the primary reasons behind these wasted healthcare dollars is a failure to effectively leverage data to understand patient needs—a must-have to deliver patient-centered, value-based care (VBC).
Three analytics strategies enable health systems to focus on patients while also meeting the financial standards for VBC delivery:
Prioritize patient outreach by risk level.
Deploy data tools to combat COVID-19.
Promote data literacy.
Detailed information from comprehensive data sets allows health systems to understand patient needs at a granular level and then use that insight to drive care decisions. More informed care ensures health systems are also meeting the core elements of VBC—managing costs, delivering quality, and ensuring an excellent patient experience.
Framework for Data Warehousing and Mining Clinical Records of Patients: A ReviewBRNSSPublicationHubI
This document discusses a framework for data warehousing and mining clinical records of patients. It begins with an abstract that describes how a clinical data warehouse can provide access to clinical data for healthcare providers and support areas like research and management. The rest of the document reviews the background and need for integrating disparate clinical data sources, describes challenges in current fragmented systems, and discusses the significance of developing a clinical data warehousing and mining framework to organize and extract medical records from different systems.
Payers are being challenged as the industry shifts from volume-based care to a value-based reimbursement structure that would benefit the patient, the healthcare provider and the payer. New payment models including fee-for-service only and pay-for performance creates impetus for payers to acquire, aggregate, and analyze data.
Presentation by Megan Douglas, JD for the Third Annual Policy Prescriptions® Symposium
She is the associate director of Health Information Technology Policy in the National Center for Primary Care at Morehouse School of Medicine.
The symposium is designed for clinicians, healthcare workers, and healthcare executives interested in exploring the major themes that will emerge in health policy throughout the year. This year, the symposium will emphasize value in healthcare, health information technology, gun violence, insurance choices, the Affordable Care Act, and the viewpoints of the Presidential candidates on health care.
HIMSS GSA e-Authentication whitepaper June 2007Richard Moore
HIMSS and the GSA, developed a pilot project to demonstrate the adoption of the GSA's secure and interoperable technical architecture for sharing medical information across multiple healthcare providers. The pilot utilized the GSA's E-Authentication Service Component program to provide digital certificates, technical architecture development support, and certificate validation services.
Seven RHIOs/Health Information Exchanges initially volunteered to participate in the project. One participant the Nevada Single Portal Medical Record HIE had to withdraw from the project due to a lack of resources.
Central Ohio HIE - Initiated by eHealth Ohio, and in conjunction with the Ohio Supercomputer Center, this project has focused on evaluating the viability of using the proposed national level user authentication process as a means of authenticating individual researchers, system developers and system administrators who will be both utilizing, creating and maintaining future health care research systems. An emerging area of software development focus, this pilot will also identify key issues faced by resource constrained development efforts.
Driving Home Health Efficiency through Data AnalyticsCitiusTech
This whitepaper highlights how data analytics can help track key performance indicators to drive clinical, financial and operational efficiency to improve quality of home health in an efficient manner.
Direct Boot Camp 2 0 Federal Agency requirements for exchange via directBrian Ahier
The FHA Directed Exchange Workgroup provides updates on efforts to increase the adoption of Direct for health information exchange between federal agencies and non-federal entities. They are educating federal partners on Direct technology and policies, developing common understanding of use cases and security requirements, and identifying baseline documents and FAQs. Establishing a common federal Direct policy would greatly increase its adoption for information exchange. Focused workgroups address Directed exchange, security, and interoperability issues. Risks to Directed exchange between agencies are being identified and recommendations will be provided to ONC.
Suggested ResourcesThe resources provided here are optional. You.docxdeanmtaylor1545
Suggested Resources
The resources provided here are optional. You may use other resources of your choice to prepare for this assessment; however, you will need to ensure that they are appropriate, credible, and valid. The MHA-FP5064 Health Care Information Systems Analysis and Design for Administrators Library Guide can help direct your research, and the Supplemental Resources and Research Resources, both linked from the left navigation menu in your courseroom, provide additional resources to help support you.
The Role of Informatics in Health Care
The following articles address the increasingly important role of informatics, which may provide useful insight when examining the data needs of an organization.
· Centers for Medicare & Medicaid Services. (2017). Data and program reports. Retrieved from https://www.cms.gov/regulations-and-guidance/legislation/ehrincentiveprograms/dataandreports.html
. The Web page provides access to Medicare and Medicaid Electronic Health Records Incentive Program payment and registration data contained in various reports.
· Chen, M., Lukyanenko, R., & Tremblay, M. C. (2017). Information quality challenges in shared healthcare decision making. Journal of Data and Information Quality (JDIQ), 9(1), 1–3.
. Discusses the challenges for patients in making sense of the enormous volume of health information made available through current information and communications technologies and how the quality of that information affects shared decision-making between patients and providers.
· Crawford, M. (2014). Making data smart. Journal of AHIMA, 85(2), 24–27, 28.
. Discusses applied informatics and how it can be used to derive useful information from big data, as health care becomes a data-driven industry.
· Dinov, I. D. (2016). Methodological challenges and analytic opportunities for modeling and interpreting big healthcare data. GigaScience, 5(1), 1–15.
. Discusses the challenges of big data analysis and addresses the need for technology and education in creating valuable knowledge assets from big data.
· Hegwer, L. R. (2014). Digging deeper into data. Healthcare Financial Management, 68(2), 80–84.
. Discusses the role of data analysts in improving the financial and clinical performance of health care organizations.
2
Running Head: Organizational Data needs
2
Organizational Data needs
Organization Data Needs Capella UniversityAssignment 2
Internal data sources can include data systems, for example, a radiology data system, medical library data, or the patient finance and billing system. Internal data sources also include EHR data systems such as the demographics, medical history of patients and disease records, medication and allergies records, laboratory test results, personal patient statistics such as gender age, weight and billing information (Porter et al, 2018).
External data sources include data from Centres for Medicare and Medicaid Services (CMS), benchmarking data from other hospitals are ex.
Adventure Works Marketing PlanCentralizing Medical Information.docxgalerussel59292
Adventure Works Marketing Plan
Centralizing Medical Information To Improve Patient Care
(
Centralizing Medical Information To Improve patient Care
)
Contents
Centralizing Medical Information To Improve patient Care0
Contents1
History2
Executive Summary2
High-Level Functional Requirements:4
Project Charter4
Business Problem Statement5
Project Scope5
Budget and Schedule6
Strategy6
SWOT ANALYSIS6
Technology Constraints7
Project Documentation and Communication9
Project Organization and Staffing Approach9
Project Value Statement9
History
The Affordable Care Act law was passed to improve healthcare for its citizens in the United States by increasing the people that have health insurance and by decreasing healthcare cost. A benefactor to this law is the Medicare/Medicaid program which provides medical coverage to the poor, elderly and disabled individuals which is funded by the federal government. The Federal government covers funding for Medicare programs while it provides reimbursement funds for Medicaid programs provided by the states. (The National Federation Of Independent Business V Sebellius, Secretary Of Health And Human Services, 2012). The primary benefits of the Affordable Care Act Law are covering more consumers with improved quality of services while reducing healthcare cost, access to healthcare, and consumer protection. (ASPA, 2014) Centers For Medicare and Medicaid Services (CMS) manages both of these programs and by modernizing and strengthening the current system they will be lowering cost and providing quality care. Executive Summary
The Center for Medicare and Medicaid (CMS) is the federal office to organized the integration of Medicaid and Medicare services across multiple agencies nationwide. Its purpose is to improve access to services, improve coordination of services, and improve cost of services. Medical services cost billions of dollars to both the state and federal government; therefore, lowering the cost of these entities while providing valuable and improved services serves its mission. In complying with the mission of CMS, our team will provide a centralized database solution that will solve the following business problems:
· Efficient access to patient medical information by emergency personnel
· Integrated access to vital medical history and medication
· Patient access to their health record
· Decrease duplication of test by doctors
· Reduce fraud
· Improve patient care
· Reduce medical cost
· Improve patient outcome(About the Medicare-Medicaid Coordination Office, 2015)
The table below Figure 1 shows Medicare/Medicaid spending with and without reform and shows that with reform, great savings can be accomplished over time with cost savings measures such as the a centralized database.
Figure 1
The new system will provide the following functionalities:
High-Level Functional Requirements:
· Automation of process for maintaining medical records:
1. Access medical information through Pin Number..
> Definition of RWD
> RWD - Big Data Characteristics
> Sources of RWD
> Important Stakeholders
> Benefits of RWD
> Why Data Sharing is Important?
> Benefits of Data Sharing
> Who Benefits?
> Ultimate Goals
> Case Studies
> Challenges
> Data Privacy Scenario
> Data Security in India
> Regulatory Perspectives Around RWD
> How to Encourage Data Sharing?
Unit VI Case StudyAnimal use in toxicity testing has long been .docxdickonsondorris
Unit VI: Case Study
Animal use in toxicity testing has long been a controversial issue; however, there can be benefits. Read “The Use of Animals in Research,” which is an article that can be retrieved from http://www.toxicology.org/pubs/docs/air/AIR_Final.pdf.
Evaluate the current policies outlined in the Position Statement on page 5 of the article. Use the SOT Guiding Principles in the Use of Animals in Toxicology to guide you in your analysis. Feel free to use additional information and avenues of information, including the textbook, to critically analyze this policy.
In addition, answer the following questions:
How do toxicologists determine which exposures may cause adverse health effects?
How does the information apply to what you are learning in the course?
What were the objectives of this toxicity testing?
What were the endpoints of this toxicity testing?
Finally, include whether or not you agree with the Society of Toxicology's position on animal testing.
Your Case Study assignment should be three to four pages in length. Use APA style guidelines in writing this assignment, following APA rules for formatting, quoting, paraphrasing, citing, and referencing.
Adventure Works Marketing Plan
Centralizing Medical Information To Improve Patient Care
(
Centralizing Medical Information To Improve patient Care
)
Contents
Centralizing Medical Information To Improve patient Care0
Contents1
History2
Executive Summary2
High-Level Functional Requirements:4
Project Charter4
Business Problem Statement5
Project Scope5
Budget and Schedule6
Strategy6
SWOT ANALYSIS6
Technology Constraints7
Project Documentation and Communication9
Project Organization and Staffing Approach9
Project Value Statement9
History
The Affordable Care Act law was passed to improve healthcare for its citizens in the United States by increasing the people that have health insurance and by decreasing healthcare cost. A benefactor to this law is the Medicare/Medicaid program which provides medical coverage to the poor, elderly and disabled individuals which is funded by the federal government. The Federal government covers funding for Medicare programs while it provides reimbursement funds for Medicaid programs provided by the states. (The National Federation Of Independent Business V Sebellius, Secretary Of Health And Human Services, 2012). The primary benefits of the Affordable Care Act Law are covering more consumers with improved quality of services while reducing healthcare cost, access to healthcare, and consumer protection. (ASPA, 2014) Centers For Medicare and Medicaid Services (CMS) manages both of these programs and by modernizing and strengthening the current system they will be lowering cost and providing quality care. Executive Summary
The Center for Medicare and Medicaid (CMS) is the federal office to organized the integration of Medicaid and Medicare services across multiple agencies nationwide. Its purpose is to improve access to services, ...
Addressing the Healthcare Connectivity ChallengeTodd Winey
In healthcare, information accessibility can impact the outcome of a medical decision, or the success of a bundled payment initiative. To ensure that the right information is available at the right place and time, healthcare organizations typically have used HL7® interface engines to share data among clinical applications. But the demands on healthcare information technology are changing so rapidly that these simple engines are no longer sufficient.
Similar to Deborah Gersh, Data in Value- Based Health Care (20)
Personal protective equipment or PPE has been a major topic of discussion across the nation. The COVID-19 pandemic has exposed major shortages of PPE and health care workers are being asked take care of patients with what some would argue is inadequate protection. The guidelines set by the CDC have changed and recommendations have even gone so far as to approve bandannas as a means for respiratory protection. Some have argued that it is unethical for health care workers to not have adequate protection, while others think it's their duty, protected or not. Adding to this debate has been theft, hoarding and disparate distribution of these critical supplies. During this panel discussion moderator Carmel Shachar, Stephen P. Wood, Christine Mitchell and Dr. Michael Mina explored the ethics of PPE in the COVID-19 pandemic.
March 27, 2020
Each year in low- and middle-income countries thousands of people are detained in hospitals for non-payment of medical bills, despite the fact that such detention is a violation of national and international law. Hospital detention for nonpayment of bills disproportionately affects the most vulnerable people, including post-partum women.
In the US, medical debt manifests itself in other ways, including bankruptcy, litigation to garnish wages, and foregone care. In both contexts, these scandals are the result of failures of financing, priority-setting, and legal oversight.
Without addressing these systemic issues, a "human right to health care" will remain a hollow slogan, as will political promises to achieve universal health coverage.
This event will feature Robert Yates of Chatham House, which has conducted an in-depth investigation of the global phenomenon of hospital detentions. Additional panelists will address manifestations of predatory lending and surprise medical fees in the United States, the ethical imperatives of financing and priority setting for UHC in general, and the implications for thinking about health care as a human right.
For more information, visit our website at: https://petrieflom.law.harvard.edu/events/details/debt-dignity-and-health-care
March 24, 2020
This event will highlight the challenges and opportunities in harnessing artificial intelligence (AI) technologies to serve the needs of individuals with disabilities and dependencies. AI can improve the lives of people with disabilities, such as smart devices supporting people with physical disabilities or sight loss. On the other hand, AI outputs can also reflect discriminatory biases present in the underlying data used to develop the algorithms. While this “garbage in, garbage out” principle is well documented in respect to AI and gender or race, it is understudied in respect to disability or dependencies.
Interdisciplinary panels of legal scholars, ethicists, AI developers, medical and service providers, and advocates with disabilities/ dependencies will explore best practices and guidelines for stakeholders, guided by ethical principles, legal considerations, and the needs of people with disabilities/ dependencies. Participants will seek to articulate clear criteria for developers and medical providers looking to harness the potential of AI to serve individuals with disabilities/ dependencies, including those whose disabilities/ dependencies are the result of aging, injury, or disease, and the caregivers -- including both professionals and unpaid friends and families -- who support some of these individuals.
This webinar was free and open the public.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/artificial-intelligence-and-disability-dependency
March 24, 2020
This event will highlight the challenges and opportunities in harnessing artificial intelligence (AI) technologies to serve the needs of individuals with disabilities and dependencies. AI can improve the lives of people with disabilities, such as smart devices supporting people with physical disabilities or sight loss. On the other hand, AI outputs can also reflect discriminatory biases present in the underlying data used to develop the algorithms. While this “garbage in, garbage out” principle is well documented in respect to AI and gender or race, it is understudied in respect to disability or dependencies.
Interdisciplinary panels of legal scholars, ethicists, AI developers, medical and service providers, and advocates with disabilities/ dependencies will explore best practices and guidelines for stakeholders, guided by ethical principles, legal considerations, and the needs of people with disabilities/ dependencies. Participants will seek to articulate clear criteria for developers and medical providers looking to harness the potential of AI to serve individuals with disabilities/ dependencies, including those whose disabilities/ dependencies are the result of aging, injury, or disease, and the caregivers -- including both professionals and unpaid friends and families -- who support some of these individuals.
This webinar was free and open the public.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/artificial-intelligence-and-disability-dependency
February 14, 2020
On February 14, 2020, Harvard Medical School Center for Bioethics and the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center hosted the monthly health policy consortium on sugar-sweetened beverage excise taxes.
In recent years, some cities have tried to impose soda taxes and other new policies to reduce the obesity epidemic in the US—particularly among children—and its critical impact on society and the health care system. How effective are these policies? What is blocking their uptake? What alternatives should we consider?
For more information visit our website at: https://petrieflom.law.harvard.edu/events/details/soda-taxes-and-other-policy-responses-to-the-american-obesity-epidemic
February 14, 2020
On February 14, 2020, Harvard Medical School Center for Bioethics and the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center hosted the monthly health policy consortium on sugar-sweetened beverage excise taxes.
In recent years, some cities have tried to impose soda taxes and other new policies to reduce the obesity epidemic in the US—particularly among children—and its critical impact on society and the health care system. How effective are these policies? What is blocking their uptake? What alternatives should we consider?
For more information visit our website at: https://petrieflom.law.harvard.edu/events/details/soda-taxes-and-other-policy-responses-to-the-american-obesity-epidemic
October 23, 2019
The future of neuroscience and law will be a computational future, as both fields are increasingly integrating artificial intelligence and machine learning. But what will this future look like? Can AI and digital technologies promote justice, diversity, and inclusion? Or will these technologies replicate, or even exacerbate, existing inequalities and biases? In this lunchtime event, leading experts in artificial intelligence, computational psychiatry, and the law discussed these questions as they explored how AI and digital technologies can advance social good through improved social, psychiatric, and legal interventions.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/computational-justice
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
October 7, 2019
On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly.
There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health.
For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar
September 10, 2019
Book Talk: Birth Rights and Wrongs: How Medicine and Technology are Remaking Reproduction and the Law
Millions of Americans rely on the likes of birth control, IVF, and genetic testing to make plans as intimate and far-reaching as any over a lifetime. This is no less than the medicine of miracles. It fills empty cradles, frees families from terrible disease, and empowers them to fashion their lives on their own terms. But accidents happen.
Pharmacists mix up pills. Lab techs misread tests. Obstetricians tell women their healthy fetuses would be stillborn. Political and economic forces conspire against regulation. And judges throw up their hands when professionals foist parenthood on people who didn't want it, or childlessness on those who did. Failed abortions, switched donors, and lost embryos may be first-world problems. But these aren't innocent lapses or harmless errors. They're wrongs in need of rights.
At this event, author Dov Fox and an expert panel discussed his book Birth Rights and Wrongs: How Medicine and Technology are Remaking Reproduction and the Law (Oxford University Press, 2019). Panelists explored the ways in which the book seeks to lift the curtain on reproductive negligence, give voice to the lives it upends, and vindicate the interests that advances in medicine and technology bring to full expression. They also examined the book's effort to force citizens and courts to rethink the reproductive controversies of our time, and to equip us to meet the new challenges -- from womb transplants to gene editing -- that lie just over the horizon.
Learn more: https://petrieflom.law.harvard.edu/events/details/book-talk-birth-rights-and-wrongs
September 10, 2019
Book Talk: Birth Rights and Wrongs: How Medicine and Technology are Remaking Reproduction and the Law
Millions of Americans rely on the likes of birth control, IVF, and genetic testing to make plans as intimate and far-reaching as any over a lifetime. This is no less than the medicine of miracles. It fills empty cradles, frees families from terrible disease, and empowers them to fashion their lives on their own terms. But accidents happen.
Pharmacists mix up pills. Lab techs misread tests. Obstetricians tell women their healthy fetuses would be stillborn. Political and economic forces conspire against regulation. And judges throw up their hands when professionals foist parenthood on people who didn't want it, or childlessness on those who did. Failed abortions, switched donors, and lost embryos may be first-world problems. But these aren't innocent lapses or harmless errors. They're wrongs in need of rights.
At this event, author Dov Fox and an expert panel discussed his book Birth Rights and Wrongs: How Medicine and Technology are Remaking Reproduction and the Law (Oxford University Press, 2019). Panelists explored the ways in which the book seeks to lift the curtain on reproductive negligence, give voice to the lives it upends, and vindicate the interests that advances in medicine and technology bring to full expression. They also examined the book's effort to force citizens and courts to rethink the reproductive controversies of our time, and to equip us to meet the new challenges -- from womb transplants to gene editing -- that lie just over the horizon.
Learn more: https://petrieflom.law.harvard.edu/events/details/book-talk-birth-rights-and-wrongs
May 17, 2019
Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing.
As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics.
Presentation: Vardit Ravitsky, Associate Professor, Bioethics Programs, Department of Social and Preventive Medicine, School of Public Health, University of Montreal; Director, Ethics and Health Branch, Center for Research on Ethics - Prenatal Genome Sequencing: Ethical and Regulatory Implications for Post-Birth Access to Information
Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference
May 17, 2019
Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing.
As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics.
Presentation: Liza Vertinsky, Associate Professor of Law, Emory University School of Law and Emory Global Health Institute Faculty Fellow (with Yaniv Heled) - Genetic Privacy and Public Figures
Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference
May 17, 2019
Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing.
As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics.
Presentation: Scott Schweikart, Senior Research Associate, Council on Ethical and Judicial Affairs, American Medical Association and Legal Editor, AMA Journal of Ethics - Human Gene Editing: An Ethical Analysis and Arguments for Regulatory Guidance at Both the National and Global Levels
Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference
May 17, 2019
Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing.
As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics.
Presentation: Emily Qian, Genetic Counselor, Veritas Genetics (with Magalie Leduc, Rebecca Hodges, Bryan Cosca, Ryan Durigan, Laurie McCright, Doug Flood, and Birgit Funke) - Physician-Mediated Elective Whole Genome Sequencing Tests: Impacts on Informed Consent
Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference
More from The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics (20)
Acute complications of sickle cell disease .pdfRawanAlakwaa
This presentation displays the acute complications of sickle cell disease. It starts by presenting a real case of a child admitted to the hospital because of one of these complications…
Motivational Interviewing (MI) is a therapeutic approach that helps individuals find the motivation to make positive behavioral changes. By fostering a collaborative, empathetic, and non-judgmental dialogue, MI empowers clients to explore their ambivalence about change and strengthen their commitment to personal goals. This method is effective in various settings, including addiction treatment, health behavior change, and mental health.
The temporomandibular joint (TMJ) is a pivotal component in prosthodontics due to its complex biomechanics and role in mandibular function. The TMJ consists of the mandibular condyle and the temporal bone, with an articular disc in between, facilitating smooth movement. Its biomechanics involve a combination of rotational and translational movements, essential for mastication, speech, and other mandibular activities. Understanding TMJ function is crucial in prosthodontics for diagnosing and treating disorders, designing prostheses, and ensuring proper occlusion and jaw alignment. Accurate assessment and management of the TMJ can significantly impact the success and comfort of prosthetic treatments
Comprehensive understanding of arm balancing asana
Benefits of arm balancing asana
Arm balancing asanas have numerous benefits, including:
Strengthening the arms and shoulders: Arm balancing asanas require a lot of strength in the upper body, particularly the arms and shoulders. Regular practice of these asanas can help to build muscle and increase strength in these areas.
Improving balance and stability: Arm balancing asanas challenge your balance and stability, which can help to improve your overall coordination and body awareness.
Boosting confidence and concentration: Successfully mastering arm balancing asanas can give you a sense of accomplishment and help to build your confidence. Additionally, the concentration required to maintain the balance in these asanas can help to improve focus and concentration.
Stimulating the digestive system: Some arm balancing asanas, such as Bakasana (Crow Pose), can stimulate the digestive system and aid in digestion.
Energizing the body: Arm balancing asanas can help to energize the body and improve circulation, which can lead to increased vitality and overall well-being.
Developing core strength: Arm balancing asanas require a strong core, and practicing these poses can help to develop the muscles of the abdomen and lower back.
Improving flexibility: Many arm balancing asanas require flexibility in the hips, hamstrings, and other areas of the body. Regular practice can help to increase overall flexibility and range of motion.
Contraindications of arm balancing asana
Arm balancing asanas are advanced yoga postures that require strength, flexibility, and stability in the upper body. As such, they can be challenging and have certain contraindications. Some of the contraindications of arm balancing asanas are:
Wrist or shoulder injury: Arm balancing asanas can put a lot of pressure on the wrists and shoulders. If you have a history of wrist or shoulder injury, or if you are currently experiencing pain or discomfort in these areas, it is best to avoid these postures or modify them with the guidance of an experienced teacher.
High blood pressure: Some arm balancing asanas, such as headstand and handstand, can increase blood pressure. If you have high blood pressure, it is important to avoid these postures or practice them under the guidance of a qualified teacher who can help you modify them to make them safe.
Neck injury: Certain arm balancing asanas, such as crane pose and peacock pose, require placing weight on the head and neck. If you have a neck injury, it is best to avoid these postures or modify them with the guidance of an experienced teacher.
Pregnancy: Arm balancing asanas can be risky for pregnant women, especially in the later stages of pregnancy. If you are pregnant, it is important to avoid these postures or practice them only under the guidance of a qualified prenatal yoga teacher.
Inexperienced practitioners: Arm balancing asanas require a certain level of streng
Positive Parenting: Raising Happy, Confident Children | UCSinfo513572
This presentation explores Positive Parenting: strategies, benefits, and how United Community Solution (UCS) classes empower parents with expert guidance, interactive learning, and support to raise happy, confident children. Read more: https://unitedcommunitysolution.com/service/parenting-classes/
DM Pharma is one of the top 10 antibiotic manufacturers in India, known for its dedication to quality and innovation. They produce a wide range of antibiotic medications, ensuring effective treatment for various bacterial infections. With state-of-the-art facilities and strict quality control measures, DM Pharma consistently delivers safe and reliable products. Their commitment to excellence has earned them a strong reputation in the pharmaceutical industry. As a leading manufacturer, DM Pharma continues to meet the growing demand for high-quality antibiotics, making a significant impact on healthcare in India and beyond.
EFFECTIVE & SCIENTIFICALLY PROVEN WEIGHT LOSS PROGRAMMoses Alonge
Supper and Scientifically Proven Methods for Effective Weight Loss. It's safe and highly effective with notable results in just few days. You don't need all the "chemical pills" that endanger your health and leave your life at the risk of the attendant adverse effects.
Believe me: it has been tested and trusted over time with high success rate.
Check it out here:
https://3w105.doctortrf.com/l/?sub1
2025 QPP: Proposed Changes from the PFS Proposed RuleShelby Lewis
CMS has released the 2025 PFS Proposed Rule and proposed several changes to the Quality Payment Program. Here is a slideshow that highlights the key changes.
Week 8 Case of Tiana-DIAGNOSIS OF FEEDING AND EATING DISORDERS CASE STUDY.pdfReliable Assignments Help
Struggling with your assignment on the diagnosis of feeding and eating disorders? Look no further! At Reliableassignmentshelp.com, we provide comprehensive support to help you navigate and complete your assignment with ease. Feeding and eating disorders are complex and require a nuanced understanding, and our expert assistance ensures you grasp these complexities effectively.
Why Choose Us?
1. Expert Writers:
Our team is composed of experienced professionals in the fields of psychology, mental health, and medical sciences. They bring a wealth of knowledge and practical insights, ensuring your assignment is handled with the highest level of expertise. Our writers stay updated with the latest research and developments in diagnosing feeding and eating disorders.
2. Comprehensive Support:
We cover a broad spectrum of feeding and eating disorders, including but not limited to:
Anorexia Nervosa
Bulimia Nervosa
Binge-Eating Disorder
Avoidant/Restrictive Food Intake Disorder (ARFID)
Other Specified Feeding or Eating Disorder (OSFED)
Pica and Rumination Disorder
Our assistance extends to understanding the diagnostic criteria outlined in the DSM-5, recognizing the symptoms, and exploring various treatment modalities.
3. Tailored Solutions:
Each assignment we handle is customized to meet your specific requirements and academic standards. We ensure that the content is relevant, accurate, and aligned with your educational goals. Whether you need help with an essay, research paper, case study, or any other assignment type, we provide solutions that are tailored to your needs.
4. Plagiarism-Free Content:
Academic integrity is paramount. We guarantee 100% original work, with proper citations and references. Our content is thoroughly checked for plagiarism to ensure authenticity and originality. You can be confident that your assignment will stand up to scrutiny.
5. Timely Delivery:
We understand the importance of deadlines. Our efficient process ensures that your assignment is completed and delivered on time, without compromising on quality. We offer flexible timelines to accommodate urgent requests as well.
Our Services Include:
1. Detailed Analysis:
We provide an in-depth exploration of various feeding and eating disorders. This includes a comprehensive review of the symptoms, diagnostic criteria, risk factors, and treatment options for each disorder. Our detailed analysis helps you understand the nuances and complexities involved in diagnosing these disorders.
2. Case Studies:
We incorporate real-life examples and case studies to illustrate the variations and intricacies in diagnosing feeding and eating disorders. These case studies enhance your understanding by providing practical, real-world applications of theoretical knowledge.
3. Research Assistance:
Our experts assist you in finding and analyzing relevant academic sources. We help you identify credible research articles, books, and journals that support your assignment.
3. 3
VBHC data challenges
IT support critical for Value-based Health Care (“VBHC”)
– Major investments in Electronic Health Records (“EHRs”), but have
not met expectations
– Supporting VBHC Initiatives
– Need to build for 2020 and beyond
Grappling with the interoperability millstone – legal and operational
challenges
Seeking high quality data: rethinking the way we organize and support
the collection, management and use of the data
– Capturing and structuring data to support the shift to greater
provider accountability
4. 4
Quality of data
Data not effectively captured or measured
Need for:
– Effective sharing of data with integrated care team
– Use of data for benchmarking purposes
– Support for evidenced-based care planning
– Support for Clinically Integrated Networks (“CINs”), Risk-bearing
Organizations (“RBOs”), Health Information Exchanges (“HIEs”)
5. 5
Diabetes as example
Range of
clinical and
supplemental
needs
Pre-admission / screening
In hospital care
Post acute care
Physical Therapy
Diet and exercise
Patient Engagement through technology
Ancillary Support Services
6. 6
Privacy protections – the counterpoint
Strong public policy preference: protecting patient privacy and
data-use rights
The conflict: desire to have benefits of big data but reluctance to
share personal health information
Fragmentation of these protections
– Like EHRs, patient privacy protections built around the legacy
fee-for-service health care structure and patient consents and
authorizations
7. 7
Array of data-use rights & privacy protections
Legal hurdles
– Authorizations and consents
Non-“treatment” uses and data aggregation
Patient compensation for data; blockchain technology?
Coordination of consents and authorizations across the care
team
Authorization of future, unforeseen uses (de-identification,
“blanket” consents)
Effective data security
State-specific privacy laws (HIV, mental health, etc.)
Ongoing compliance with evolving federal standards
– Office for Civil Rights enforcement
– Punitive shift in Federal Trade Commission enforcement
8. 8
Balancing the values
Balancing patient privacy legal protections with the data sharing and
aggregation required for VBHC:
– Trusted Exchange Framework (“TEFCA”), a partial answer
– Pursuant to the 21st Century Cures Act
– Attempts to create a single “on-ramp” for provider and others’
data exchange
– CINs
Difficult to establish
Still require substantial resources devoted to privacy
– Complex to ascertain needed consents/authorizations
Business associate or covered entity status, and when?
– New York State Medicaid Health Home program
– Broad state-authored consent and authorization
– Substantial compliance resources still required
9. 9
Balancing the values
– HIEs
Exchanges of clinical information between disparate health
systems
Variety of models (e.g., EHR vendors, consumer controlled,
geographic based)
Still fundamentally rests upon a concept of consents and
authorizations
– Emerging trends
United Health Group
– Payor provided data analytics and technology
– Supporting Medicare advanced Bundled Payments for Care
Improvement model
CVS – Aetna
– Wellness clinics and pharma services
– Community-based hub
10. 10
Conclusion
The move to VBHC requires harmonizing competing goals:
(1) data sharing and aggregation necessary for VBHC
(2) the moral and legal imperatives of patient privacy and control